Aprogen Medicines (007460.KS) Dividend: History, Dates & Yield - 2024
Tags:Dividend History
Aprogen Medicines announced a annually dividend of ₩37.51 per ordinary share, payable on , with an ex-dividend date of 2007-12-27. Aprogen Medicines typically pays dividends one times a year.
Find details on Aprogen Medicines's dividend performance with a comprehensive history of past and upcoming payments.
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2007-12-27 | ₩37.51 | annually | |
| 2006-12-27 | ₩37.51 | annually | |
| 2005-12-28 | ₩37.51 | annually |
Dividend Increase
. In comparison, 011780.KS has seen an average growth rate of 45.16% over the past five years and 012200.KS's growth rate was -5.71%.
By comparing Aprogen Medicines's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Aprogen Medicines's current trailing twelve-month (TTM) dividend yield is nan%. Over the last 12 months, Aprogen Medicines has maintained this yield, but how does it compare to similar stocks? For example, 011780.KS offers a yield of 3.17%, while 012200.KS provides a yield of 1.50%. Comparing similar stocks can help investors assess Aprogen Medicines's yield and make more informed decisions.
| Company | Dividend Yield | Annual Dividend | Stock Price |
|---|---|---|---|
| Aprogen Medicines (007460.KS) | NaN% | ₩37.5089 | ₩776 |
| 011780.KS (011780.KS) | 3.17% | $2900 | $91500 |
| 012200.KS (012200.KS) | 1.5% | $25 | $1664 |
Dividend Yield Calculator
Interested in purchasing Aprogen Medicines stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Aprogen Medicines has a payout ratio of 0.00%. In comparison, Aprogen pharmaceuticals has a payout ratio of 0.00%, while Hanall Biopharma's payout ratio is 0.00%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Aprogen Medicines
- Global presence The company operates in multiple countries worldwide
- Key Segments Dividend investors should be aware of the company's main business segments
- Products/Services The company offers a diverse range of products and services
- Financial stability The company's overall financial health is strong and stable, a positive sign for dividend investors.
Frequently Asked Question
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Aprogen Medicines stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.